|
Volumn 16, Issue 1, 2001, Pages 9-21
|
How valuable are animal models in defining antidepressant activity?
|
Author keywords
Animal models; Antidepressants; Chronic mild stress; Forced swim; Learned helplessness; Olfactory bulbectomy
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPRAZOLAM;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
APOMORPHINE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BUSPIRONE;
CENTRAL STIMULANT AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOMIPRAMINE;
CLONIDINE;
FLUOXETINE;
GEPIRONE;
HALOPERIDOL;
KETANSERIN;
METITEPINE;
MONOAMINE OXIDASE INHIBITOR;
NEUROLEPTIC AGENT;
ONDANSETRON;
PINDOLOL;
RISPERIDONE;
SCOPOLAMINE;
SEDATIVE AGENT;
SEROTONIN 1 AGONIST;
SEROTONIN UPTAKE INHIBITOR;
SULPIRIDE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHRONIC MILD STRESS;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
CONTROLLED STUDY;
DEPRESSION;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG SCREENING;
FORCED SWIMMING TEST;
LABORATORY;
LEARNED HELPLESSNESS;
MOUSE;
NEUROLOGIC DISEASE;
NONHUMAN;
OLFACTORY BULBECTOMY;
PREDICTION;
PRIORITY JOURNAL;
RAT;
REPRODUCIBILITY;
STRESS;
THEORY;
TIME;
VALIDATION PROCESS;
|
EID: 0035100705
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/hup.178 Document Type: Article |
Times cited : (154)
|
References (79)
|